The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Open accessAbstract
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology. These recommendations provide a data-supported approach to establishing guidelines. They are based on the following: (1) a formal review and analysis of the recently published world literature on the topic (Medline search up to September 2008); (2) the American College of Physicians' Manual for Assessing Health Practices and Designing Practice Guidelines;1 (3) guideline policies, including the American Association for the Study of Liver Diseases' (AASLD) Policy on the Development and Use of Practice Guidelines and the American Gastroenterological Association's Policy Statement on the Use of Medical Practice Guidelines;2 and (4) the experience of the authors in regard to hepatitis C. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation (Table 1, adapted from the American College of Cardiology and the American Heart association Practice Guidelines).3, 4 AASLD, American Association for the Study of Liver Diseases; ALT, alanine aminotransferase; ANC, absolute neutrophil count; anti-HCV, antibody to HCV; AST, aspartate aminotransferase; CKD, chronic kidney disease; CTP, Child-Turcotte-Pugh; EIA, enzyme immunoassay; ETR, end-of-treatment response; EVR, early virological response; FDA, U.S. Food and Drug Administration; HCV, hepatitis C virus; HIV, human immunodeficiency virus; PCR, polymerase chain reaction; PEG, polyethylene glycol; RVR, rapid virological response; SVR, sustained virological response; ULN, upper limit of normal. The hepatitis C virus (HCV) is a major public health problem and a leading cause of chronic liver disease.5 An estimated 180 million people are infected worldwide.6 In the United States (U.S.), the prevalence of HCV infection between the years 1999 and 2002 was 1.6%, equating to about 4.1 million persons positive for antibody to hepatitis C (anti-HCV), 80% of whom are estimated to be viremic.7 Hepatitis C is the principal cause of death from liver disease and the leading indication for liver transplantation in the U.S.8 Some calculations suggest that mortality related to HCV infection (death from liver failure or hepatocellular carcinoma) will continue to increase over the next two decades.9 The purpose of this document is to provide clinicians with evidence-based approaches to the prevention, diagnosis, and management of HCV infection. The optimal approach to detecting HCV infection is to screen persons for a history of risk of exposure to the virus, and to test selected individuals who have an identifiable risk factor.10 Currently, injection drug use is the primary mode of HCV transmission in the U.S; thus, all persons who use or have used illicit injection drugs in the present or past, even if only once, as well as intranasal drug users who share paraphernalia, should be tested for HCV infection.7, 11, 12 Individuals who have received a blood or blood component transfusion or an organ transplant before 1992 should also be tested. With the introduction of sensitive tests to screen blood donors for HCV antibodies in 1992, transfusion-transmission of HCV has become rare.12, 13 Persons with hemophilia should be tested for HCV infection if blood products were received before 1987, after which time, viral inactivation procedures were implemented.14 Similarly, individuals with unexplained elevations of the aminotransferase levels (alanine and/or aspartate aminotransferase; ALT/AST), those ever on hemodialysis, children born to HCV-infected mothers, or those with human immunodeficiency virus (HIV) infection should be tested for the presence of HCV infection.15-17 Other potential sources of HCV transmission include exposure to an infected sexual partner or multiple sexual partners, exposure among health care workers to HCV-contaminated blood and blood products, and tattooing.12, 15, 18-23 The prevalence of HCV infection is consistently higher among persons with multiple sexual partners, whereas sexual transmission of HCV between monogamous partners is uncommon.11, 18 Thus, although it is prudent to counsel HCV-infected persons to notify their current partners of their HCV status, they should be informed that the risk of sexual transmission is sufficiently low19 that many authorities do not advise the use of barrier protection among monogamous couples.18 Nevertheless, between 1% and 5% of monogam
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Sexually Transmitted Diseases Treatment Guidelines, 2006
Skolnik, N. S. (2007) · Current Clinical Practice · doi:10.1007/978-1-59745-313-4_17 · Cited by 3,124
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
Sandrin, L., Fourquet, B., Hasquenoph, J.-M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.07.001 · Cited by 2,738
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04396-4 · Cited by 2,093
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C., Maertens, G., et al. (2005) · Hepatology · doi:10.1002/hep.20819 · Cited by 1,516
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Self-citationFattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
An Update on Terminology and Reporting
Batts, K. P., & Ludwig, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00007 · Cited by 1,080
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolf, R. A., Jones, E., Dsiney, A. P., Briggs, D., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06154-1 · Cited by 878
Chung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Self-citationPeginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I. F., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00100 · Cited by 832
Self-citationDavis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 816
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Vento, S., Garofano, T., Renzini, C., Cainelli, F., Casali, F., Ghironzi, G., Ferraro, T., & Concia, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380503 · Cited by 795
Global challenges in liver disease
Williams, R. (2006) · Hepatology · doi:10.1002/hep.21347 · Cited by 788
Acute viral hepatitis increases liver stiffness values measured by transient elastography
Arena, U., Vizzutti, F., Corti, G., Ambu, S., Stasi, C., Bresci, S., Moscarella, S., Boddi, V., Petrarca, A., Laffi, G., et al. (2008) · Hepatology · doi:10.1002/hep.22007 · Cited by 754
Lack of Protective Immunity Against Reinfection with Hepatitis C Virus
Farci, P., Alter, H. J., Govindarajan, S., Wong, D. C., Engle, R., Lesniewski, R. R., Mushahwar, I. K., Desai, S. M., Miller, R. H., Ogata, N., et al. (1992) · Science · doi:10.1126/science.1279801 · Cited by 752
HCV-related fibrosis progression following liver transplantation: increase in recent years
Berenguer, M., Ferrell, L., Watson, J., Prieto, M., Kim, M., Rayón, M., Córdoba, J., Herola, A., Ascher, N., Mir, J., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80231-7 · Cited by 748
Alter, H. J., & Seeff, L. B. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9505 · Cited by 736
Self-citationSherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002) · Clinical Infectious Diseases · doi:10.1086/339042 · Cited by 733
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Transmission of Hepatitis C Virus from Mothers to Infants
Ohto, H., Terazawa, S., Sasaki, N., Sasaki, N., Hino, K., Ishiwata, C., Kako, M., Ujiie, N., Endo, C., Matsui, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301103 · Cited by 663
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
Bruno, S., Stroffolini, T., Colombo, M., Bollani, S., Benvegnù, L., Mazzella, G., Ascione, A., Santantonio, T., Piccinino, F., Andreone, P., et al. (2007) · Hepatology · doi:10.1002/hep.21492 · Cited by 604
Poynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50267 · Cited by 604
Veldt, B. J., Heathcote, E. J., Wedemeyer, H., Reichen, J., Hofmann, W. P., Zeuzem, S., Manns, M. P., Hansen, B. E., Schalm, S. W., & Janssen, H. L. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-10-200711200-00003 · Cited by 602
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Interferon Alfa-2a Therapy in Cryoglobulinemia Associated with Hepatitis C Virus
Misiani, R., Bellavita, P., Fenili, D., Vicari, O., Marchesi, D., Sironi, P. L., Zilio, P., Vernocchi, A., Massazza, M., Vendramin, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301104 · Cited by 583
Tattoos and body piercings in the United States: A national data set
Laumann, A. E., & Derick, A. J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.03.026 · Cited by 579
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2027 · Cited by 571
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548302006-001 · Cited by 564
Diagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Berenguer, M., Prieto, M., Rayón, J. M., Mora, J., Pastor, M., Ortiz, V., Carrasco, D., Juan, F. S., Burgueño, M.-D.-J., Mir, J., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.17924 · Cited by 544
Muir, A. J., Bornstein, J. D., & Killenberg, P. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032502 · Cited by 541
Surveillance for acute viral hepatitis--United States, 2006.
Wasley, A., Grytdal, S., & Gallagher, K. (2008) · PubMed · Cited by 535
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
Sagir, A., Erhardt, A., Schmitt, M., & Häussinger, D. (2008) · Hepatology · doi:10.1002/hep.22056 · Cited by 513
Ferenci, P., Fried, M. W., Shiffman, M. L., Smith, C. I., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.009 · Cited by 512
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
Glue, P. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110973 · Cited by 504
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Shiffman, M. L., Suter, F., Bacon, B. R., Nelson, D., Harley, H., Solá, R., Shafran, S. D., Barange, K., Lin, A., Soman, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066403 · Cited by 493
Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 489
Vogt, M. O., Lang, T., Frösner, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411202 · Cited by 488
Neuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Self-citationConjeevaram, H. S., Fried, M. W., Jeffers, L. J., Terrault, N. A., Wiley–Lucas, T. E., Afdhal, N., Brown, R. S., Belle, S. H., Hoofnagle, J. H., Kleiner, D. E., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.008 · Cited by 472
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Di Bisceglie, A. M., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Everhart, J. E., Wright, E. C., Lee, W. M., Lok, A. S., Bonkovsky, H. L., Morgan, T. R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707615 · Cited by 465
Self-citationShiffman, M. L., Di Bisceglie, A. M., Lindsay, K. L., Morishima, C., Wright, E. C., Everson, G. T., Lok, A. S., Morgan, T. R., Bonkovsky, H. L., & Lee, W. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.014 · Cited by 453
Shiffman, R. N., Shekelle, P., Overhage, J. M., Slutsky, J., Grimshaw, J., & Deshpande, A. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00013 · Cited by 451
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
McHutchison, J. G., Dusheiko, G., Shiffman, M. L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S. C., Campbell, F. M., Theodore, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073255 · Cited by 448
Protection against persistence of hepatitis C
Mehta, S. H., Cox, A., Hoover, D. R., Wang, X.-H., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08435-0 · Cited by 440
Self-citationAlberti, A., & Benvegnù, L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00008-4 · Cited by 438
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Psychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Natural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
Self-citationMast, E. E., Hwang, L., Seto, D. S. Y., Nolte, F. S., Nainan, O. V., Wurtzel, H., & Alter, M. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497701 · Cited by 396
Surveillance for acute viral hepatitis--United States, 2005.
Wasley, A., Miller, J. T., & Finelli, L. (2007) · PubMed · Cited by 392
Laguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., Bargallo, X., García-Criado, A., Lazzari, E. D., Larrousse, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00003 · Cited by 387
Conte, D., Fraquelli, M., Prati, D., Colucci, A., & Minola, E. (2000) · Hepatology · doi:10.1002/hep.510310328 · Cited by 383
(2008) · Kidney International · doi:10.1038/ki.2008.81 · Cited by 377
Steatosis: Co-factor in Other Liver Diseases *
Powell, E. E., Jonsson, J. R., & Clouston, A. D. (2005) · Hepatology · doi:10.1002/hep.20750 · Cited by 374
The role of liver biopsy in chronic hepatitis C
Dienstag, J. L. (2002) · Hepatology · doi:10.1002/hep.1840360720 · Cited by 373
Hepatitis C and renal disease: an update
Meyers, C. M., Seeff, L. B., Stehman-Breen, C. O., & Hoofnagle, J. H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00828-x · Cited by 365
Self-citationTreatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Noninvasive Measures of Liver Fibrosis
Rockey, D. C., & Bissell, M. D. (2006) · Hepatology · doi:10.1002/hep.21046 · Cited by 349
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Carrión, J. A., Navasa, M., García-Retortillo, M., García‐Pagán, J. C., Crespo, G., Bruguera, M., Bosch, J., & Forns, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.041 · Cited by 347
Pessione, F., Degos, F., Marcellin, P., Duchatelle, V., Njapoum, C., Martinot-Peignoux, M., Degott, C., Valla, D., Erlinger, S., & Rueff, B. (1998) · Hepatology · doi:10.1002/hep.510270635 · Cited by 340
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Corrao, G., & Aricò, S. (1998) · Hepatology · doi:10.1002/hep.510270404 · Cited by 324
Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R., Martin, G., Schindlbeck, N., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50031 · Cited by 324
Alter, M. J., Kuhnert, W. L., & Finelli, L. (2003) · PubMed · Cited by 320
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
Lafeuillade, A., Hittinger, G., & Chadapaud, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03618-7 · Cited by 319
Prevention of spread of hepatitis C
Alter, M. J. (2002) · Hepatology · doi:10.1053/jhep.2002.36389 · Cited by 319
Jacobson, I. M., Brown, R. S., Freilich, B., Afdhal, N., Kwo, P. Y., Santoro, J., Becker, S., Wakil, A. E., Pound, D., Godofsky, E., et al. (2007) · Hepatology · doi:10.1002/hep.21932 · Cited by 304
The burden of hepatitis C in the United States
Kim, R. W. (2002) · Hepatology · doi:10.1002/hep.1840360705 · Cited by 299
Sexual activity as a risk factor for hepatitis C
Terrault, N. A. (2002) · Hepatology · doi:10.1053/jhep.2002.36797 · Cited by 298
Steatosis affects chronic hepatitis C progression in a genotype specific way
Rubbia-Brandt, L., Fabris, P., Paganin, S., Leandro, G., Male, P.-J., Giostra, E., Carlotto, A., Bozzola, L., Smedile, A., & Negro, F. (2004) · Gut · doi:10.1136/gut.2003.018770 · Cited by 297
Yu, M., Dai, C., Huang, J., Hou, N., Lee, L.-P., Hsieh, M., Chiu, C.-F., Lin, Z.-Y., Chen, S., Hsieh, M., et al. (2006) · Gut · doi:10.1136/gut.2006.102558 · Cited by 286
(2003) · PsycEXTRA Dataset · doi:10.1037/e545982006-001 · Cited by 280
Complementary and alternative medicine in chronic liver disease
Seeff, L. B., Lindsay, K. L., Bacon, B. R., Kresina, T. F., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.27445 · Cited by 271
Self-citationPearlman, B. L., Ehleben, C., & Saifee, S. (2007) · Hepatology · doi:10.1002/hep.21919 · Cited by 269
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
Neumann, U. P., Berg, T., Bahra, M., Puhl, G., Guckelberger, O., Langrehr, J. M., & Neuhaus, P. (2004) · Transplantation · doi:10.1097/01.tp.0000101738.27552.9d · Cited by 268
Fibrosis and disease progression in hepatitis C
Marcellin, P., Asselah, T., & Boyer, N. (2002) · Hepatology · doi:10.1002/hep.1840360707 · Cited by 267
Association of Hepatitis C with Posttransplant Diabetes in Renal Transplant Patients on Tacrolimus
Bloom, R. D., Rao, V., Weng, F., Grossman, R. A., Cohen, D., & Mange, K. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000012382.97168.e0 · Cited by 263
Tattoos and Body Piercings as Indicators of Adolescent Risk-Taking Behaviors
Carroll, S. T., Riffenburgh, R. H., Roberts, T. A., & Myhre, E. B. (2002) · Pediatrics · doi:10.1542/peds.109.6.1021 · Cited by 258
Hepatitis C: the clinical spectrum of the disease
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80368-7 · Cited by 257
Treatment of Hepatitis C Infection in Injection Drug Users
Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25882 · Cited by 256
Olynyk, J. K., Reddy, K. R., di Bisceglie, A. M., Jeffers, L. J., Parker, T. I., Radick, J. L., Schiff, E. R., & Bacon, B. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90209-0 · Cited by 254
Bellentani, S., Pozzato, G., Saccoccio, G., Crovatto, M., Crocè, L. S., Mazzoran, L., Masutti, F., Cristianini, G., & Tiribelli, C. (1999) · Gut · doi:10.1136/gut.44.6.874 · Cited by 246
Zeuzem, S., Diago, M., Gane, E., Reddy, K. R., Pockros, P., Prati, D., Shiffman, M., Farci, P., Gitlin, N., O’Brien, C. B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.050 · Cited by 246
Ghobrial, R. M., Steadman, R., Gornbein, J., Lassman, C., Holt, C. D., Chen, P., Farmer, D. G., Yersiz, H., Danino, N., Collisson, E., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00012 · Cited by 243
Molecular diagnosis of viral hepatitis
Pawlotsky, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33428 · Cited by 240
National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002
Seeff, L. B., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1053/jhep.2002.36992 · Cited by 239
Self-citationPuoti, C., Magrini, A., Stati, T., Rigato, P., Montagnese, F., Rossi, P., Aldegheri, L., & Resta, S. (1997) · Hepatology · doi:10.1002/hep.510260603 · Cited by 234
Contribution of obesity to hepatitis C-related fibrosis progression
Ortiz, V (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04352-6 · Cited by 233
Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
Cox, A. L., Netski, D. M., Mosbruger, T., Sherman, S. G., Strathdee, S., Ompad, D., Vlahov, D., Chien, D., Shyamala, V., Ray, S. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428578 · Cited by 231
Self-citationLane, H. C., Davey, V., Kovacs, J. A., Feinberg, J., Metcalf, J. A., Herpin, B., Walker, R., Deyton, L., Davey, R. T., Falloon, J., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-11-805 · Cited by 228
The clinical pharmacology of ribavirin.
Glue, P. (1999) · PubMed · Cited by 217
Lindahl, K., Ståhle, L., Bruchfeld, A. N., & Schvarcz, R. (2005) · Hepatology · doi:10.1002/hep.20563 · Cited by 215
Kamal, S. M., Fouly, A. E., Kamel, R. R., Hockenjos, B., Al Tawil, A., Khalifa, K. E., He, Q., Koziel, M. J., El Naggar, K. M., Rasenack, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.034 · Cited by 215
Pradat, P. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00105-2 · Cited by 211
Molecular Diagnostics of Hepatitis C Virus Infection: A Systematic Review
Scott, J. D., & Gretch, D. R. (2007) · JAMA · doi:10.1001/jama.297.7.724 · Cited by 209
Fabrizi, F., Martin, P., Dixit, V., Bunnapradist, S., Kanwal, F., & Dulai, G. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01040.x · Cited by 208
Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
Edlin, B. R., Seal, K. H., Lorvick, J., Kral, A. H., Ciccarone, D. H., Moore, L. D., & Lo, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450311 · Cited by 202
Rowe, I. A., Webb, K., Gunson, B. K., Mehta, N., Haque, S., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2007.00628.x · Cited by 199
Duclos-Vallée, J.-C., Féray, C., Sebagh, M., Teicher, E., Roque-Afonso, A.-M., Roche, B., Azoulay, D., Adam, R., Bismuth, H., Castaing, D., et al. (2008) · Hepatology · doi:10.1002/hep.21990 · Cited by 195
Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., Seeff, L. B., & for the National Heart, L. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00012 · Cited by 194
Self-citationJadoul, M., Cornu, C., de Strihou, C. V. Y., & (UCL) Collaborative Group \ (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00823.x · Cited by 193
Iacobellis, A., Siciliano, M., Perri, F., Annicchiarico, B. E., Leandro, G., Caruso, N., Accadia, L., Bombardieri, G., & Andriulli, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.020 · Cited by 192
Jara, P., Resti, M., Hierro, L., Giacchino, R., Barbera, C., Zancan, L., Crivellaro, C., Sokal, E., Azzari, C., Guido, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/345908 · Cited by 190
Persistent hepatitis C viraemia without liver disease
Brillanti, S., Foli, M., Gaiani, S., Masci, C., Miglioli, M., & Barbara, L. (1993) · The Lancet · doi:10.1016/0140-6736(93)90210-8 · Cited by 190
Treating hepatitis C in methadone maintenance patients: an interim analysis
Sylvestre, D. L. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00010-8 · Cited by 189
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers
Lin, H.-H., Kao, J.-H., Hsu, H.-Y., Ni, Y.-H., Chang, M.-H., Huang, S.-C., Hwang, L.-H., Chen, P.-J., & Chen, D.-S. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70356-x · Cited by 189
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study
Wiese, M., Grüngreiff, K., Güthoff, W., Lafrenz, M., Oesen, U., & Porst, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.007 · Cited by 187
Use of complementary and alternative medicine in patients with liver disease
Strader, D. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04350-2 · Cited by 186
Self-citationUremic Bleeding: Pathogenesis and Therapy
Weigert, A. L., & Schafer, A. I. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40384-2 · Cited by 185
Soriano, V., Garcia-Samaniego, J., Bravo, R., Gonzalez, J., Castro, A., Castilla, J., Martinez-Odriozola, P., Colmenero, M., Carballo, E., Suarez, D., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.585 · Cited by 175
Mother-to-Infant Transmission of Hepatitis C Virus
Wejstål, R., Widell, A., Månsson, A.-S., Hermodsson, S., & Norkrans, G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-11-887 · Cited by 168
Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial
Nomura, H., Sou, S., Tanimoto, H., Nagahama, T., Kimura, Y., Hayashi, J., Ishibashi, H., & Kashiwagi, S. (2004) · Hepatology · doi:10.1002/hep.20196 · Cited by 168
Lee, W. M., Dienstag, J. L., Lindsay, K. L., Lok, A. S., Bonkovsky, H. L., Shiffman, M. L., Everson, G. T., Di Bisceglie, A. M., Morgan, T. R., Ghany, M. G., et al. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.003 · Cited by 167
Self-citationLocatelli, F., Nissenson, A. R., Barrett, B. J., Walker, R. G., Wheeler, D. C., Eckardt, K. U., Lameire, N. H., & Eknoyan, G. (2008) · Kidney International · doi:10.1038/ki.2008.299 · Cited by 166
Nainan, O. V., Alter, M. J., Kruszon-Moran, D., Gao, F.-X., Xia, G., McQuillan, G., & Margolis, H. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.007 · Cited by 166
Fontana, R. J., Israel, J., LeClair, P., Banner, B. F., Tortorelli, K., Grace, N., Levine, R. A., Fiarman, G., Thiim, M., Tavill, A. S., et al. (2000) · Hepatology · doi:10.1002/hep.510310325 · Cited by 165
Labarga, P., Soriano, V., Vispo, M. E., Pinilla, J., Martín‐Carbonero, L., Castellares, C., Casado, R., Maida, I., García‐Gascó, P., & Barreiro, P. (2007) · The Journal of Infectious Diseases · doi:10.1086/520092 · Cited by 165
Meta‐analysis: interferon for the treatment of chronic hepatitis C in dialysis patients
Fabrizi, F., Dulai, G. S., Dixit, V. K., Bunnapradist, S., & Martin, P. B. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01780.x · Cited by 165
Stein, M. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00144-7 · Cited by 161
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
Samuel, D., Forns, X., Berenguer, M., Trautwein, C., Burroughs, A., Rizzetto, M., & Trepo, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.001 · Cited by 161
Sánchez-Fueyo, A., Restrepo, J. C., Quintó, L., Bruguera, M., Grande, L., Sánchez-Tapias, J. M., Rodés, J., & Rimola, A. (2002) · Transplantation · doi:10.1097/00007890-200201150-00010 · Cited by 160
Bizollon, T., Ahmed, S. N. S., Radenne, S., Chevallier, M., Chevallier, P., Parvaz, P., Guichard, S., Ducerf, C., Baulieux, J., Zoulim, F., et al. (2003) · Gut · doi:10.1136/gut.52.2.283 · Cited by 160
Wong, J. B., & Koff, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00008 · Cited by 155
Deuffic‐Burban, S., Poynard, T., Sulkowski, M., & Wong, J. B. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00785.x · Cited by 151
Firpi, R. J., Zhu, H., Morelli, G., Abdelmalek, M. F., Soldevila‐Pico, C., Machicao, V. I., Cabrera, R., Reed, A., Liu, C., & Nelson, D. R. (2005) · Liver Transplantation · doi:10.1002/lt.20532 · Cited by 151
Sexual activity as a risk factor for hepatitis C
Terrault, N. A. (2002) · Hepatology · doi:10.1002/hep.1840360713 · Cited by 148
Westin, J., Lagging, M., Spak, F., Aires, N., Svensson, E., Lindh, M., Dhillon, A. P., Norkrans, G., & Wejstål, R. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00356.x · Cited by 144
Haji, S. A., Starling, R. C., Avery, R. K., Mawhorter, S. D., Tuzcu, E. M., Schoenhagen, P., COOK, D. J., Ratliff, N. B., McCarthy, P. M., Young, J. B., et al. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(03)00148-7 · Cited by 142
National institutes of health consensus development conference: Management of hepatitis C: 2002
Seeff, L. B., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360702 · Cited by 142
Self-citationScreening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals
Thio, C. L., Nolt, K. R., Astemborski, J. A., Vlahov, D., Nelson, K. E., & Thomas, D. L. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.575-577.2000 · Cited by 141
Self-citationSchaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M. G. L., Schwaiger, M., Sarkar, R., Friebe, A., Heinz, A., Kluschke, M., et al. (2007) · Hepatology · doi:10.1002/hep.21791 · Cited by 140
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro
Hoggard, P. G., Kewn, S., Barry, M. G., Khoo, S., & Back, D. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1231 · Cited by 139
(1998) · PEDIATRICS · doi:10.1542/peds.101.3.481 · Cited by 135
Yılmaz, N., Shiffman, M. L., Stravitz, R. T., Sterling, R. K., Luketic, V. A., Sanyal, A. J., Mills, A. S., Contos, M. J., COTTERELL, A. H., Maluf, D. G., et al. (2007) · Liver Transplantation · doi:10.1002/lt.21117 · Cited by 133
Seeff, L. B., Curto, T. M., Szabó, G., Everson, G. T., Bonkovsky, H. L., Dienstag, J. L., Shiffman, M. L., Lindsay, K. L., Lok, A. S.-F., Bisceglie, A. M. D., et al. (2007) · Hepatology · doi:10.1002/hep.22044 · Cited by 132
Self-citationStravitz, R. T., Shiffman, M. L., Sanyal, A. J., Luketic, V. A., Sterling, R. K., Heuman, D. M., Ashworth, A., Mills, A. S., Contos, M. J., COTTERELL, A. H., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20189 · Cited by 132
Oton, E., Bárcena, R., Planas, J. M. M., Cuervas‐Mons, V., Moreno‐Zamora, A., Barrios, C., García-Garzón, S., Moreno, A. M., Boullosa-Graña, E., Rubio-González, E., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01470.x · Cited by 128
National Surveillance of Dialysis‐Associated Diseases in the United States, 1997
Tokars, J. I., Miller, E. R., Alter, M. J., & Arduino, M. J. (2000) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2000.00026.x · Cited by 128
Yu, J., Wang, G., Sun, L., Li, X., & Li, S. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04904.x · Cited by 128
Mazzaferro, V., TAGGER, A., Schiavo, M., Regalia, E., Pulvirenti, A., Ribero, M. L., Coppa, J. C., Romito, R., Burgoa, L., Zucchini, N., et al. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02508-2 · Cited by 127
Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00109-5 · Cited by 126
Mele, A., Corona, R., Tosti, M. E., et al. (1995) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549509047042 · Cited by 125
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users
Chamot, E., Hirschel, B. J., Wintsch, J., Robert, C.-F., Gabriel, V., Déglon, J., Yerly, S., & Perrin, L. H. (1990) · AIDS · doi:10.1097/00002030-199012000-00016 · Cited by 124
Alvarez, D., Dieterich, D. T., Bräu, N., Moorehead, L., Ball, L., & Sulkowski, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00749.x · Cited by 121
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Metadata
- Authors
- Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B.
- Venue
- Hepatology
- Published
- 2009-04
- Volume
- 49
- Issue
- 4
- Pages
- 1335-1374
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2113864802
- Cited by
- 2,973
- References
- 266
- FWCI
- 141.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.